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Abstract.  We examined the metabolism and intracellu- 
lar transport of the D-erythro and L-threo 
stereoisomers of a fluorescent analogue of sphingomye- 
lin, N-(  N-[  6-[  (  7-nitrobenz-  2-oxa-l,3-d iazol-4-y  l )amino] 
caproyl])-sphingosylphosphorylcholine (C6-NBD-SM), 
in Chinese hamster ovary (CHO-K1)  fibroblast mono- 
layers.  C6-NBD-SM  was integrated into the plasma 
membrane bilayer by transfer of C6-NBD-SM 
monomers from liposomes to cells at 7°C.  The cells 
were washed, and within 10-15  min of being warmed 
to 37°C,  C6-NBD-SM  was internalized from the 
plasma membrane to a perinuclear location that 
colocalized with the centriole and was distinct from 
the lysosomes and the Golgi apparatus.  This 
perinuclear region was also labeled by internalized 
rhodamine-conjugated transferrin. C6-NBD-SM  en- 
docytosis was not inhibited when the microtubules 
were disrupted with nocodazole; rather, the fluorescent 
lipid was distributed in vesicles throughout the cell pc- 
riphery instead of being internalized to the perinuclear 
region of the cell. The metabolism of C6-NBD-SM  to 
other fluorescent sphingolipids at 37°C  and its effect 
on C6-NBD-SM  transport was also examined. 
To study plasma membrane lipid recycling,  C6-NBD- 
SM was first inserted into the plasma membrane of 
CHO-K1  cells and then allowed to be internalized by 
the cells at 37°C.  Any C6-NBD-SM  remaining at the 
plasma membrane was then removed by incubation 
with nonfluorescent liposomes at 7°C, leaving cells 
containing only internalized fluorescent lipid.  The re- 
turn of C6-NBD-SM  to the plasma membrane from in- 
tracellular compartments upon further 37°C  incubation 
was then observed. The half-time for a complete 
round C6-NBD-SM  recycling between the plasma 
membrane and intracellular compartments was ~40 
min. Pretreatment of cells with either monensin or 
nocodazole did not inhibit C6-NBD-SM  recycling. 
ECYC LING of plasma membrane receptors is a process 
involving membrane vesicle budding,  fusion/fission 
and transport (10, 38). Since intracellular vesicles are 
involved in all known steps of the recycling process,  there 
should also be considerable  lipid transport  in conjunction 
with  protein  recycling.  However, no  direct  evidence  for 
plasma membrane lipid recycling between intracellular com- 
partments  and the cell surface is available. 
Previous  work  in  our laboratory  used  fluorescent  acyl 
chain-labeled glycerolipids as probes for studying endocyto- 
sis in cultured cells (32, 37). However, these probes are not 
practical for studies of lipid recycling because such studies 
require  prolonged  incubations  at  37°C during  which  the 
fluorescent glycerolipids are extensively hydrolyzed by cel- 
lular phospholipases,  releasing fluorescent  fatty acid  (37). 
Since sphingomyelin (SM)'  is a major lipid constituent of 
the plasma membrane that is highly resistant to acyl chain 
hydrolysis (1), we have used a fluorescent  analog  of SM, 
N-(N-[6-[(7-nitrobenz-2-oxa-l,3-diazol-4-y/) amino]caproyl])- 
sphingosylphosphorylcholine (C6-NBD-SM), to circumvent 
this problem  in the present  study. Using Chinese  hamster 
ovary fibroblast cell line (CHO-K1) cells, we examined the 
internalization  of this  fluorescent  lipid  from  the  plasma 
membrane to intracellular compartments, and its subsequent 
return to the plasma membrane ("recycling") with time. We 
also studied the effect of SM stereochemistry on its metab- 
olism  and  intracellular  transport  using  stereoisomers  of 
C6-NBD-SM corresponding to the natural D-erythro or non- 
natural L-threo  forms of  SM. Finally, the patterns of intracel- 
lular labeling obtained with C6-NBD-SM were compared to 
those of a recycling protein to learn whether the same com- 
partments are involved in lipid and protein recycling. 
This work is in partial  fulfillment of the requirements for a doctoral degree 
by M. Koval in the Department of Biology, The Johns Hopkins University, 
Baltimore,  MD. 
1. Abbreviations used in this paper: Cer, ceramide; CHO-KI, Chinese ham- 
ster ovary fibroblast cell line; DOPC, dioleoylphosphatidylcholine;  GlcCer, 
glucosylceramide; HCMF,  10 mM  Hepes-buffered  calcium and magne- 
sium-free  Puck's saline, pH 7.4; HMEM, Hepes-buffered  MEM; LUVET, 
large unilamellar vesicle by extrusion techniques; C6-NBD, N-[6-[(7-nitro- 
benz-2-oxa-l,3-diazol-4-yl)amino]caproyl];  C6-NBD-Cer,  N-(C6-NBD)- 
sphingosine; C6-NBD-GIcCer, N-(C6-NBD)-glucosylsphingosine;  C6-NBD- 
SM,  N-(C6-NBD)-sphingosylphosphorylcholine;  Rh,  rhodamine;  Rh-Tf, 
Rh-conjugated  transferrin;  SM,  sphingomyelin;  SRh,  sulforhodamine; 
SUV, small unilamellar vesicle. 
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Materials 
Dioleoylphosphatidylcholine  (DOPC)  and  dioleoylphosphatidylethanol- 
amine were obtained from Avanti Polar Lipids, Inc. (Birmingham, AL). C6- 
NBD-aminohexanoic acid,  sulforhodamine chloride and sulforhodamine 
dextran, 10 kD (SRh-dextran) were purchased from Molecular Probes Inc. 
(Eugene, OR). Sodium cacodylate was from Electron Microscopy Sciences 
(Fort Washington, PA).  Triphenylphosphine was from Aldrich Chemical 
Co. (Milwaukee, WI). All organic solvents were purchased from Burdick 
& Jackson Laboratories Inc. (Muskegon, MI). Rhodamine(Rh)-conjugated 
second antibodies were from Organon Teknika-Cappel (West Chester, PA). 
Rh-conjugated Ricinus communis agglutinin 120 was purchased from Vector 
Laboratories,  Inc.  (Burlingame,  CA).  Unless otherwise stated,  all  other 
materials were obtained from Sigma Chemical Co.  (St.  Louis, MO). 
Cell Culture 
Monolayer cultures of CHO-K1 fibroblasts (CCL 61; American Type Cul- 
ture Collection, Rockville, MD) were grown in MEM Alpha medium (No. 
410-2000; Gibco Laboratories, Grand Island, NY) supplemented with 5 % 
FBS in a water-saturated atmosphere of 5 % CO2 in air.  Cells were grown 
for 48-72 h on No. 1 thickness, 25-mm acid-washed glass coverslips to 20% 
confluency for microscopy, or on 60-mm plastic tissue culture dishes to 
80%  confluency for biochemical analysis. 
Lipid Synthesis and Analysis 
C6-NBD-SM  was synthesized from C6-NBD-fatty acid and  sphingosyl- 
phosphorylcholine by  oxidation-reduction condensation with  triphenyl- 
phosphine and 2-2'-dipyridyldisulflde (19, 24). TLC of the reaction mixture 
on silica gel 60 plates (E. Merck, Darmstadt, FRG) developed in CHCI3/ 
CH3OH/28%  NH4OH/H20  (72:48:2:9,  vol/vol/vol/vol)  resolved  two 
products, C6-NBD-SM1  (Rf =  0.31) and C6-NBD-SM2 (Rf =  0.36), both 
having the expected molecular mass of 740.9 D as determined by mass spec- 
trometry. 
Samples of each  C6-NBD-SM  isomer were  hydrolyzed to  C6-NBD- 
ceramide (Cer) using sphingomyelinase (human placenta) in vitro as previ- 
ously described (25). Reverse-phase HPLC (33) of the resulting fluorescent 
Cers showed that hydrolysis of C6-NBD-SM1  produced only D-erythro-C6- 
NBD-Cer,  while hydrolysis of C6-NBD-SM2 produced only L-threo-C6- 
NBD-Cer.  Thus,  we identified C6-NBD-SM1  as D-erythro-C6-NBD-SM 
and C6-NBD-SM2 as L-threo-C6-NBD-SM. 
N-Sul  forhodamine(SRh)-conjugated  dioleoylphosphatidylethanolamine 
(43) and N-(C6-NBD)-o-erythro-sphingosine (C6-NBD-Cer; 33) were syn- 
thesized and purified as previously described. Concentrations of lipid stock 
solutions were determined by phosphorus measurement (35) or by reference 
to known concentrations of fluorescent standards. 
Lipid Vesicles 
Small unilamellar vesicles (SUV) were formed by ethanol injection (20) as 
follows. C6-NBD-SM and DOPC (typically 2:3;  mol/mol) were mixed in 
chloroform/methanol (2:1),  dried first under nitrogen, then in vacuo,  and 
dissolved in ethanol (2.8 mM total lipid concentration). This ethanol solu- 
tion  was  injected into  17.5 vol  of 10  mM  Hepes-buffered calcium and 
magnesium-free Puck's saline (HCMF) while vortex-mixing. The vesicle 
preparation was dialyzed at 4°C overnight against Hepes-buffered MEM, 
pH 7.4 (HMEM), and diluted to a final concentration of 25 ~M total lipid 
in HMEM (unless otherwise specified). 
DOPC vesicles for the back-exchange procedure (see below) were pre- 
pared as large unilamellar vesicles by extrusion (LUVET) as follows (14). 
DOPC in chloroform was dried first under nitrogen, then in vacuo, and sus- 
pended into 2 ml HCMF to obtain a final DOPC concentration of 10-40 
mM. This suspension was frozen in liquid nitrogen, thawed at 37°C, frozen 
and thawed again, and then passed 10 times through two stacked 25-mm 
polycarbonate filters (0.1/xm pore size; Nuclepore Corp., Pleasanton, CA) 
in an extruder device (Lipex Biomembranes, Inc., Vancouver,  Canada) at 
250 lb/in  2. The resulting LUVETs were diluted with HMEM to a final con- 
centration of 400 ~M DOPC in HMEM. 
Incubation of  Lipid Vesicles with Cells 
Monolayer cultures  were cooled to  7°C  for 5  min,  washed twice with 
HMEM and then incubated with vesicles containing fluorescent lipid, typi- 
cally using 25 #M C6-NBD-SM/DOPC (2:3; mol/mol) SUV in HMEM at 
7°C for 30 min (standard conditions). Incubations were stopped by washing 
the cells three times with cold HMEM. In most experiments, the cultures 
were subsequently warmed to 37°C by adding prewarmed HMEM to the 
cells and incubating at 37°C in a water-saturated incubator. 
To remove C6-NBD-SM associated with the plasma membrane, the cells 
were back-exchanged (37, 40)  by incubating at 7°C with back-exchange 
medium  (DOPC  LUVETs  in  HMEM;  see above).  The  back-exchange 
medium was replaced every 5 min with fresh 7°C back-exchange medium 
for a total  of six treatments. 
After back-exchange, cultures sometimes were further incubated at 37°C 
with either prewarmed HMEM  alone or prewarmed HMEM containing 
back-exchange medium (to remove any C6-NBD-lipid transported to the 
plasma membrane during the second 37°C incubation). After each 15-min 
period of reincubation at 37°C, the medium was replaced with the same type 
of prewarmed medium. 
Analysis of Fluorescent Lipid Metabolism 
Monolayer cultures of cells treated with fluorescent lipid were scraped into 
1 ml HMEM with a policeman (Teflon, Wilmington, DE). The culture dish 
was washed with an additional  1 ml HMEM that was combined with the 
cell suspension. The cell suspension was centrifuged at 500 g for 5 min at 
4°C, and the resulting cell pellet was resuspended in 200 ~1 HMEM. A 40- 
/zl aliquot of this suspension was assayed for DNA content with either bis- 
benzimide H 33258 (21) or diphenylamine (23) using a salmon sperm DNA 
standard. Triton X-100 was addedto the remaining 160 #1 to a fnal concen- 
tration of 1% (wt/vol), and the NBD and SRh fluorescence was measured 
using a fluorimeter (model 8000C;  SLM Instruments, Inc., Urbana, IL). 
The amounts of C6-NBD-SM or N-SRh-dioleoyl phosphatidylethanolamine 
in HMEM present were determined by reference to standard curves. 
To examine C6-NBD-SM metabolism, the cell pellet was resuspended in 
900/zl HMEM. A  100-#1 aliquot of this suspension was assayed for DNA 
content, and the lipids were extracted from the remaining 800 p.l using the 
procedure of Bligh and Dyer (3) using 0.9% NaCI and 10 mM HCI in the 
aqueous phase. Lipid extracts were chromatographed on silica gel 60 thin- 
layer plates using CHCI3/CH3OH/28%  NH4OH/H20 (72:48:2:9,  vol/vol/ 
vol/vol) as the developing solvent. TLC plates were analyzed quantitatively 
as follows. A Newvicon camera (Dage-MTI Inc., Michigan City, IN) was 
used to obtain a video image of a TLC plate illuminated by UV light. The 
video image was then digitized using an IP-512  image processing system 
(Imaging Technology, Inc., Woburn, MA). Regions of the digitized image 
corresponding to areas of the plate containing a single C6-NBD-lipid spe- 
cies were identified by the operator as regions to be quantified. Blank areas 
adjacent to selected regions were used to determine the amount of back- 
ground signal resulting from the TLC plate. The amount of NBD fluores- 
cence was then calculated as the difference between the total intensity within 
each region and the background intensity.  Absolute amounts of the C6- 
NBD-lipid species were determined by  reference to  known amounts of 
fluorescent lipid chromatographed and analyzed under the same conditions. 
Calculation of  Results 
The percentage of C6-NBD-SM removed by the back-exchange process % 
(C6-NBD-SM)rem was calculated using the equation 
%(C6-NBD-SM)rem  =  [1  -  ((C6-NBD-SM)Bx/ 
(C6-NBD-SM)tot)]  ×  100,  (1) 
where the amount of C6-NBD-SM was determined as pmole fluorescent 
SM/#g  DNA  in  both  back-exchanged cells  (C6-NBD-SM)ax  and  non- 
back-exchanged cells (C6-NBD-SM)tot.  The amount of C6-NBD-lipid re- 
moved by back-exchange reflects the amount of fluorescent lipid located at 
the plasma membrane (25,  27, 37, 44). 
The amount of newly synthesized C6-NBD-SM in o-erythro-C6-NBD- 
SM-labeled cells was calculated from the amount of cell-associaled C6- 
NBD-glucosylceramide (GIcCer) by: 
(newly synthesized C6-NBD-SM)  =  1.41 • (C6-NBD-GIcCer),  (2) 
where 1.41 was the ratio of C6-NBD-SM to C6-NBD-GIcCer synthesized 
by CHO-K1  cells following incubation with D-erythro-C6-NBD-Cer (see 
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mined by: 
(nonmetabolized Ct-NBD-SM)  =  (total C6-NBD-SM)  - 
(newly synthesized Ct-NBD-SM).  (3) 
Values in Eqs. 2 and 3 were determined as pmole Ct-NBD-SM/#g DNA. 
Microscopy and Rh-Transferrin Labeling Procedures 
A microscope (model IM-35, Carl Zeiss, Inc., Thornwood, NY) equipped 
with epifluorescence optics was used. Filter combinations eliminated cross- 
over between NBD and rhodamine fluorescence channels. 
Rhodamine-conjugated transferrin (Rh-Tf) was kindly provided by Drs. 
T.  McGraw and  E  Maxfield (Columbia University).  For colocalization 
studies,  ceils were first labeled  with Ct-NBD-SM  for  30  min  at  7°C, 
washed, and then incubated at 37°C for 30 min in HMEM containing 20 
#g/ml Rh-Tf.  The cells were then treated with back-exchange medium at 
7°C and photographed sequentially using optics appropriate for NBD and 
rhodamine fluorescence. 
Lysosome Labeling 
Lysosomes were visualized by indirect immunofluorescence using an anti- 
body to a 95-kD lysosomal glycoprotein (anti-lgp95), kindly provided by 
Drs. S. Schmid and I. Mellman (Yale University). Cells were first labeled 
with C6-NBD-SM for 30 rain at 70C and then warmed for 30 rain at 37°C, 
followed by treatment with back-exchange medium at 7°C. All remaining 
steps were performed at room temperature. The cells were fixed (22) using 
3% paraformaldehyde-0.02% glutaraldehyde in PBS for 15 rain, washed, 
and then photographed using optics appropriate for NBD fluorescence. The 
samples were then treated with 0.2 M glycine in H20 for 5 rain, followed 
by a 10-s treatment with 100% methanol at -20°C to render the cells per- 
meable to antibodies. The cells were then washed with PBS containing 0.2 % 
gelatin, and incubated with anti-lgp95 at a 1:100 dilution in PBS-gelatin for 
30 min. The cells were washed, incubated with rhodamine-conjugated rab- 
bit anti-mouse IgG at a  1:100 dilution in PBS-gelatin for 30 rain, and then 
washed with PBS. Cells previously photographed were relocated and pho- 
tographed using optics appropriate for rhodamine fluorescence. 
Alternatively, cells were labeled with C6-NBD-SM for 30 min at 70C 
and then warmed to 37°C  for  1 h  in HMEM  containing 2  mg/ml SRh- 
dextran (10 kD), followed by a  1-h incubation at 37°C in HMEM alone (6, 
39). The cells were treated with back-exchange medium at 7°C and then 
photographed  using  optics  appropriate  for  beth  NBD  and  rhodamine 
fluorescence. 
gelatin for 30 min to label the Golgi apparatus (46). The cells were washed 
with PBS-gelatin and cells previously photographed were relocated and 
photographed using optics appropriate for Rh fluorescence. 
Miscellaneous Procedures 
Nocodazole.  Ceils were preincubated with nocodazole (10 #g/ml) for 90 
min at 37°C by adding a  1000×  nocodazole stock solution (in DMSO) to 
the culture medium.  All incubation solutions contained 10 #g/ml noco- 
dazole. 
Monensin.  Cells were preincubated with monesin (10 #M) for 90 min 
at 37°C by adding a  1000×  stock solution (in ethanol) into the culture 
medium. All incubation solutions contained 10 #M monensin. 
Energy depletion was performed by incubating cells at 7°C with SUV 
containing fluorescent lipid in the presence of 5 mM sodium azide and 50 
mM 2-deoxyglucose for 30 rain, followed by 37°C incubation in HMEM 
containing 5 mM sodium azide and 50 mM 2-deoxyglucose for 30 min (37). 
Results 
C~-NBD-SM Labeling and Internalization 
The amount of spontaneous transfer of Ct-NBD-SM  from 
SUV to CHO-K1 monolayers at 7°C  was determined as a 
function of time,  SUV concentration,  or mole fraction of 
Ct-NBD-SM in the SUV (Fig.  1). The amount of each Ct- 
NBD-SM isomer incorporated into CHO-K1 cells incubated 
with  25  #M  C6-NBD-SM/DOPC  (2:3;  mol/mol)  SUV  in 
HMEM for 30 min at 7°C (standard conditions) is given in 
Table I. In some experiments, the SUV used for labeling also 
contained 2 mole % N-SRh-DOPE, a nonexchangeable fluo- 
rescent lipid marker (37, 40, 41) that provided a measure of 
SUV nonspecificaUy adsorbed to the cells.  From these ex- 
periments,  we  calculate  that  >96%  of the  cell-associated 
C6-NBD-SM fluorescence was the result of transfer of fluo- 
rescent SM to the plasma membrane of cells treated under 
standard incubation conditions. 
Cells labeled with  SUV  containing  C6-NBD-SM at 7°C 
Centriole Labeling 
Centrioles were visualized by indirect immunofluorescence using autoanti- 
body 5051  (4),  kindly provided by Drs. T.  Mitchison and M.  Kirschner  40 
<  (University of California at San Francisco). Cells were labeled with C6-  z 
NBD-SM for 30 min at 7°C and then wanned for 15 min at 37°C. All re-  o 
maining steps were performed at room temperature. The cells were fixed  ~  30 
using  1.6% paraformaldehyde in fixing buffer (0.1 M  sodium cacodylate/  ~. 
0.1 M  sucrose) for 15 min and photographed using optics appropriate for  ,~ 
NBD fluorescence. The samples were then treated with 0.1% Triton X-100  z.  20 
in fixing buffer for 3 min, washed with HCMF, and incubated with autoanti-  -  o 
body 5051 at a 1:100 dilution in HCMF for 30 min. The cells were washed,  ~. 
incubated with Rh-conjugated goat anti-human IgG at  1:200  dilution in  lo 
HCMF for 30 min, and then washed with HCME Cells previously pho- 
tographed were relocated and photographed using optics appropriate for Rh 
fluorescence. 
Golgi Complex Labeling 
Cells were labeled with 25 #M C6-NBD-Cer/DOPC (2:3; mol/mol) SUV 
o  in HMEM at 7°C for 30 rain, washed and then incubated for 30 min at 37  C 
in HMEM containing 5% FBS, conditions that have been previously used 
to label the Golgi apparatus (26).  All remaining steps were performed at 
room temperature. The cells were fixed using 3 % paraformaldehyde-0.02 % 
glutaraldehyde in PBS for 15 min, washed, and then photographed using 
optics appropriate for NBD fluorescence. The samples were then treated 
with 0.2 M  glycine in H20 for 5 min, followed by a  10-s treatment with 
100%  methanol at  -20°C to render the cells permeable to proteins. The 
cells were then washed with PBS containing 0.2%  gelatin and incubated 
with Rh-conjugated Ricinus communis agglutinin 120 at 100 #g/ml in PBS- 
a  b 
10  20  30  40  50  0.2  0.4  0.6  60 
Minutes  Mole Fraction  nmol/ml 
C 
Figure 1.  C6-NBD-SM uptake by CHO-K1 cells. (a) Cells were in- 
cubated at  7°C  with L-threo-C6-NBD-SM/DOPC  (2:3,  mol/mol) 
SUV at 25 #M total lipid concentration for various times. (b) Cells 
were incubated at 7°C with SUV containing various mole fractions 
of L-threo-C6-NBD-SM  in the SUV at 25/zM  total lipid concen- 
tration for 30 min.  (c) Cells were incubated at 7°C with L-threo- 
Ct-NBD-SM/DOPC  (2:3,  mol/mol)  SUV  at  various  total  lipid 
concentrations for 30 min. In each case, the cell-associated lipids 
were extracted,  and the amount of Ct-NBD-SM  was determined 
and  normalized to  total cell DNA  (see Materials  and  Methods). 
Data points are the mean of triplicate measurements  +  SD. 
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Plasma Membrane 
pmol/nmol cell 
SM isomer  pmol/#g cell DNA  phospholipid 
o-erythro-C6-NBD-SM  36.3  +  6.0 (n  =  6)  22.9 
L-threo-C6-NBD-SM  26.7  +  3.0 (n  =  9)  16.8 
Cells were incubated with each C6-NBD-SM  isomer under standard labeling 
conditions,  and  the  amount of specific  incorporation  of C6-NBD-SM  was 
measured. CHO-KI  cells contained  19.9 +  1.5  (n  =  3)  #g DNA/IlY'  cells 
and 31.6 5:2.8 (n =  3) nmol phospholipid/lO  6 cells. 
showed intense plasma membrane fluorescence (Fig.  2  a). 
As long as labeled cells were kept at 7°C, at least 95.5% of 
the  cell-associated  fluorescent  lipid  could  be  removed by 
back-exchange. When cells labeled at 7°C were warmed to 
37°C,  internalization  of the fluorescent lipid was observed 
(Fig. 2, b-d). With increasing time at 37°C, there was an ac- 
cumulation of fluorescent lipid in intracellular vesicles, and, 
by 10 min, most of these vesicles had been transported to a 
central, perinuclear region of the cell. For 37°C incubations 
of 30  min  or  less,  internalized  D-erythro and  L-threo-C6- 
NBD-SM showed the same labeling pattern (compare Fig. 
2 d to Fig. 3 a). Incubation of cells in the presence of 5 mM 
sodium azide and 50  mM 2-deoxyglucose inhibited  endo- 
cytosis  of C6-NBD-SM  from  the  plasma  membrane  (not 
shown),  supporting  the  notion  that  C6-NBD-SM  internal- 
ization is energy-dependent. 
When  high concentrations  of C6-NBD-SM  are  incorpo- 
rated into membranes, self-quenching of the probe can occur 
(27, 29, 37).  To determine if self-quenching of C6-NBD-SM 
was occurring, cells were labeled with C6-NBD-SM at 7°C, 
washed,  incubated  at  37°C  for  varying  amounts  of time, 
washed, and then the amount of fluorescence in the presence 
or absence of 2 % Triton X-100 was determined. The ratio of 
fluorescence in the presence or absence of Triton X-100 for 
C6-NBD-SM-labeled cells that were incubated at 37°C  for 
0,  30,  and 60 min was  1.57  +  0.07, 1.57  +  0.08,  and  1.58 
+  0.01, respectively (n =  3 in each case), suggesting that nei- 
ther the plasma membrane nor intracellular compartments 
contained  C6-NBD-SM  at  self-quenching  concentrations. 
Also, preliminary results using low light-level digital imag- 
ing microscopy have shown that CHO-K1 cells labeled with 
100-fold less C6-NBD-SM (equivalent to 0.02%  of the total 
Figure 2.  Appearance of C6-NBD-SM  labeling and internalization in CHO-K1  cells.  (a)  CHO-K1  cells were labeled with D-erythro-C6- 
NBD-SM/DOPC  (2:3, mole/mole) SUV at 25/zM total lipid concentration  for 30 min at 7°C, washed, and photographed.  Cells labeled 
as in a were washed; incubated at 37°C in HMEM for (b) 5 min, (c) 10 min, or (d) 30 min; treated with back-exchange medium at 7°C 
to remove any C6-NBD-SM remaining at the plasma membrane;  washed; and then photographed.  Bar, 10/~m. 
The Journal of Cell Biology, Volume 108,  1989  2172 Figure 3. Comparison of endocytosed C6-NBD-SM with lysosomal markers. (a and b) Cells were labeled with SUV containing L-threo- 
C6-NBD-SM for 30 min at 70C, washed, and incubated in HMEM for 30 min at 37°C. The cells were then treated with back-exchange 
medium at 7°C to remove any C6-NBD-SM remaining at the plasma membrane,  washed, fixed and photographed for C6-NBD-lipid 
fluorescence (a). The cells were subsequently rendered permeable, treated with an antilysosomal antibody (anti-lgp95), and then labeled 
with Rh-conjugated rabbit anti-mouse IgG. The cells were washed and the field previously photographed for C6-NBD-lipid fluorescence 
was rephotographed for Rh fluorescence (b). (c and d) Cells were labeled with SUV containing D-erythro-C6-NBD-SM  in HMEM for 
30 min at 7°C, washed, and incubated for 1 h at 37°C in HMEM containing 2 mg/ml SRh-dextran. The cells were then washed and further 
incubated for 1 h at 37°C in HMEM alone, treated with back-exchange medium at 7°C to remove C6-NBD-SM remaining at the plasma 
membrane, washed, and photographed for either (c) C6-NBD-lipid or (d)  SRh-dextran fluorescence. This procedure does not require 
relocation of labeled cells and thus minimizes the possibility of a change in the plane of focus during photography. Note the absence of 
NBD and SRh fluorescence colocalization (arrowheads). Bar, 10 ttm. 
cell phospholipid) endocytose fluorescent SM to the perinu- 
clear region of the cell (not shown), suggesting that the addi- 
tion of larger amounts of C6-NBD-SM to the plasma mem- 
brane was not affecting the internalization process. 
Characterization  of Compartments Labeled by 
Endocytosed C~-NBD-SM 
To determine whether internalized C6-NBD-SM was trans- 
ported to the lysosomes, cells were first labeled with fluores- 
cent SM under standard conditions and incubated for 30 min 
at 370C, followed by back-exchange. The cells were then sub- 
sequently labeled with anti-lgp95, which recognizes a 95-kD 
lysosomal glycoprotein (Fig.  3, a  and b).  Note the lack of 
lysosomes in the central region of the cell, in contrast to the 
intracellular vesicles labeled by internalized C6-NBD-lipid. 
Also, it appeared that very little  fluorescent lipid accumu- 
lated in the lysosomes under these conditions as indicated by 
a lack of probe colocalization. In a complementary experi- 
ment (Fig.  3,  c  and d),  cells  were  labeled  with  C6-NBD- 
SM under standard conditions and then incubated at 37°C for 
1 h in the presence of the fluid phase marker SRh-dextran, 
followed by a  1-h chase at 37°C in HMEM alone to insure 
that the SRh-dextran was transported to the lysosomes (39). 
Even after a 2-h incubation at 37°C,  little,  if any, C6-NBD- 
lipid appeared to have accumulated in the lysosomes. 
Cells containing internalized C6-NBD-SM were also sub- 
sequently labeled with an antibody that labels pericentriolar 
material (4).  Endocytic vesicles containing fluorescent lipid 
aggregated  around  the  centriole  in  C6-NBD-SM-labeled 
CHO-K1 cells (Fig. 4, a  and b).  Since the centriole acts as 
Koval and Pagano Plasma Membrane LipM Recycling  2173 Figure 4. Colocalization of endocytosed C6-NBD-SM with the centriole and the effect of microtubule disruption on C6-NBD-SM internal- 
ization.  In (a and b), cells were labeled  with SUV containing L-threo-C6-NBD-SM for 30 min at 7°C, washed,  and incubated  in HMEM 
for 15 min at 3"/°C. The cells were then treated  with back-exchange  medium at 7°C to remove any C6-NBD-SM remaining at the plasma 
membrane, washed,  fixed and photographed for C6-NBD-lipid fluorescence (a).  Note that the plane of focus selected does not enable the 
visualization  of fluorescently  labeled peripheral  endosomes. The cells were subsequently  rendered permeable, treated with antibody 5051, 
which recognizes pericentriolar material,  and then labeled  with Rh-conjugated goat anti-human IgG. The cells were washed and the field 
previously photographed for C6-NBD-lipid  fluorescence was rephotographed for Rh fluorescence (b).  (c) Cells  were preincubated  with 
10 #g/ml nocodazole for 90 min at 37°C in culture medium, washed,  and labeled  with SUV containing L-threo-C6-NBD-SM in HMEM 
with 10/zg/ml nocodazole. The cells were washed,  incubated with back-exchange medium containing 10/zg/ml nocodazole at 7°C to remove 
any C6-NBD-SM  remaining at the plasma membrane, washed,  and photographed. Bar,  10 #m. 
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Figure 5. Metabolism  of o-erythro and L-threo-C6-NBD-SM. Cells 
were  labeled  with  SUV containing either  (a)  n-erythro- or  (b) 
L-threo-C6-NBD-SM in HMEM for 30 min at 7°C,  washed  and 
incubated  for the  indicated  times  at 37°C  in HMEM.  The cell- 
associated lipids were extracted,  separated by TLC, and the fluores- 
cent metabolites  were measured and expressed  as a percentage of 
total cell-associated  C6-NBD-lipid. (m) C6-NBD-SM; (&) C6-NBD- 
GlcCer; (e) C6-NBD-Cer.  Data points are the mean of triplicate 
measurements. 
a  microtubule  organizing center,  the  effect of microtubule 
disruption was also examined.  In the presence of 10/zg/ml 
nocodazole, C6-NBD-SM continued to be endocytosed, how- 
ever,  microtubule  disruption  resulted  in  little  internalized 
fluorescent lipid  accumulation  in the central  region of the 
cells.  Instead,  C6-NBD-lipid  was  distributed  in  vesicles 
throughout the periphery of the cell  (Fig.  4c). 
Quantitation of  Metabolism and Endocytosis of 
C~-NBD-SM 
Cells labeled with either o-erythro or L-threo-C6-NBD-SM 
at 7°C under standard conditions and then incubated at 37°C 
metabolized C6-NBD-SM to other fluorescent sphingolipids 
(Fig. 5, a  and b). Both C6-NBD-SM isomers showed partial 
hydrolysis  to  the  corresponding  C6-NBD-Cer  isomer,  but 
only  o-erythro-C6-NBD-SM-labeled  cells  produced  C6- 
NBD-GIcCer (from C6-NBD-Cer) during the 37°C incuba- 
tion, probably because of the stereospecificity of the conver- 
sion  of C6-NBD-Cer  to  C6-NBD-GIcCer  (33).  No  other 
fluorescent lipid species,  including C6-NBD-fatty acid,  were 
produced during 37°C incubations of up to 6  h  in cells  la- 
beled with either fluorescent SM isomer. In addition, a small 
amount (1.7 _  0.7 %; n  =  3) of o-erythro-C6-NBD-SM was 
hydrolyzed to C6-NBD-Cer during the 30 min incubation at 
7°C. 
CHO-K1  cells  were  labeled  directly  with  D-erythro-C6- 
NBD-Cer and the conversion to C6-NBD-SM and C6-NBD- 
The Journal of Cell Biology, Volume  108,  1989  2174 Figure 6. C6-NBD-Cer labeling of the Golgi apparatus.  (a and b) CHO-K1 cells were labeled with SUV containing D-erythro-C6-NBD- 
Cer in HMEM for 30 min at 7°C, washed,  incubated for 30 min at 37°C in HMEM containing 5 % FBS, fixed, and then photographed 
for C6-NBD-lipid fluorescence (a). The cells were then rendered permeable, and treated with Rh-conjugated Ricinus communis agglutinin 
120, which preferentially labels the Golgi apparatus (34, 46). The cells were washed, and the field, previously photographed for C6-NBD- 
lipid fluorescence,  was rephotographed for Rh fluorescence (b). Note labeling around the perimeter of the nucleus (arrowheads). (c and 
d)  Cells  were labeled  with  SUV containing  D-erythro-C6-NBD-SM at 7°C,  washed,  incubated  for 30 min  (c) or 2 h  (d) at 37°C in 
HMEM, followed by treatment with back-exchange medium at 7°C and then photographed.  Note the appearance of fluorescence around 
the perimeter of the nucleus with increasing time at 37°C (arrowheads)  in addition to labeling of the central perinuclear region. Bar, 10 t~m. 
GlcCer during 37°C incubation was examined under a wide 
range of conditions.  Cells were labeled at 7°C for 30 min 
with C6-NBD-Cer/DOPC  (2:3,  mol/mol) SUV  (a) at con- 
centrations ranging from 3 to 50/~M total lipid, washed, and 
then incubated for 30 min at 37°C, or (b) at 25/~M total lipid, 
washed, and then incubated at 37°C for times ranging from 
5  min to 2  h.  In all cases both C6-NBD-SM and C6-NBD- 
GlcCer  were  synthesized  from fluorescent  Cer.  The  ratio 
(C6-NBD-SM  produced/C6-NBD-GlcCer  produced)  was 
1.41  +  0.33  (n  =  26).  o-erythro-C6-NBD-Cer  metabolism 
was not affected when cells were treated with either 10/~g/ml 
nocodazole or  10/~M  monensin. 
The  intracellular  distribution  of  exogenously  supplied 
D-erythro-C6-NBD-Cer  was  examined  in  CHO-K1  cells. 
Cells labeled with SUV containing fluorescent Cer at 7°C fox 
30  min  followed by  37°C  incubation  for  30  min  showed 
prominent labeling largely around the perimeter of the nu- 
cleus (Fig.  6  a).  To confirm that C6-NBD-Cer labeled the 
Golgi apparatus in CHO cells, as previously shown in other 
cell types (26),  the  intracellular distributions  of C6-NBD- 
Cer and a lectin that preferentially labels the Golgi apparatus 
(Rh-Ricinus communis agglutinin  120;  34,  46)  were com- 
pared.  As seen in Fig.  6  (a and b)"Rh-RCA and C6-NBD- 
Cer  fluorescence  extensively colocallzed,  although  subtle 
differences, possibly because of a slight change in the plane 
of focus, were observed. In contrast, ceils labeled with C6- 
NBD-SM under standard conditions and then incubated at 
37°C  for 30 min largely contained intracellular fluorescent 
lipid in a  central,  perinuclear region of the cell with little 
labeling around the perimeter of the nucleus (Fig. 6 c). How- 
ever,  with  increasing  incubation  time  at  37°C,  C6-NBD- 
SM-labeled  cells  showed  increasing  amounts  of labeling 
around the perimeter of the nucleus in addition to labeling 
of the central perinuclear region (Fig. 6 d). These data sug- 
gest that, during 37°C incubations of fluorescent SM-labeled 
cells, C6-NBD-Cer produced by the hydrolysis of C6-NBD- 
SM was transported to the Golgi apparatus. 
To  determine  whether  some  of the  cell-associated  C6- 
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Figure 7. Quantitative distribution of Ct-NBD-SM upon 37°C in- 
cubation. CHO-Ki cells were labeled with SUV containing o-eryth- 
ro-Ct-NBD-SM in HMEM for 30 rain at 7°C, washed, incubated 
at 37"C in HMEM for the indicated amount of  time, and then either 
harvested immediately or, in parallel experiments, after treatment 
with back-exchange medium at 7"C to remove any Ct-NBD-lipid 
at the plasma membrane. The cell-associated lipids were extracted 
and analyzed by TLC as described in the text. The amount of  back- 
exchangeable C~-NBD-lipid was calculated using Eq. 1 (see Mate- 
rials and Methods) and all values are expressed as percentage of 
total cell-associated C6-NBD-lipid. The amounts of newly synthe- 
sized C6-N-BD-SM and nonmetabolized C6-N-BD-SM were calcu- 
lated by Eq. 2 and 3, respectively (see Materials and Methods). 
(n) Nonmetabolized D-erythro-C6-N-BD-SM  at the plasma mem- 
brane;  (m) intracellular  nonmetabolized D-erythro-C6-N-BD-SM; 
(zx) newly synthesized D-erythro-C6-NBD-SM  at the plasma mem- 
brane;  (A)  intracellular  newly  synthesized  D-erythro-C6-NBD- 
SM. Data points are the mean of triplicate measurements. 
NBD-SM resulted from the hydrolysis of fluorescent SM to 
Ct-NBD-Cer followed by resynthesis of Ct-NBD-SM, cells 
were prelabeled with [32P]orthophosphate followed by incu- 
bation with SUV containing either o-erythro or L-threo-C6- 
NBD-SM at 7°C. The cells were then washed, incubated at 
37°C for 2 h, and the cell-associated lipids were extracted 
and analyzed by two-dimensional TLC. In both cases,  C6- 
NBD-SM  isolated  from  these  cells  had  incorporated  32p 
(not shown),  suggesting that two pools of fluorescent SM 
were present;  i.e.,  nonmetabolized and newly synthesized 
Ct-NBD-SM. 
The best resolution of C6-NBD-SM from other radiolabeled 
lipids possible by TLC was adequate for autoradiography, 
but not for quantitative determination of 32p incorporation. 
Because CHO-K1 cells directly labeled with D-erythro-Ct- 
NBD-Cer produced Ct-NBD-SM and C6-NBD-GlcCer at a 
constant ratio (1.41:1), we used the amount of cell-associated 
fluorescent GlcGer to estimate the amount of newly synthe- 
sized  Ct-NBD-SM  formed  by  D-erythro-Ct-NBD-SM-la- 
beled cells during a given experiment (Eq. 2). The amount 
of nonmetabolized Ct-NBD-SM was then calculated as the 
difference between  the  total  cell-associated  C6-NBD-SM 
and the amount of newly synthesized C6-NBD-SM (Eq. 3). 
L-threo-Ct-NBD-SM-labeled  ceils did not produce any C6- 
NBD-GIcCer;  therefore,  all  quantitation  of Ct-NBD-SM 
transport  was  done  using  o-erythro-Ct-NBD-SM-labeled 
cells. 
Fig. 7 shows the quantitative redistribution of fluorescent 
SM in a-erythro-C6-NBD-SM-labeled  CHO-K1  cells dur- 
ing a  37°C  incubation.  Ct-NBD-SM  levels at the plasma 
membrane declined as the result of  fluorescent SM endocyto- 
sis and hydrolysis to C~-NBD-Cer. The amount of endocy- 
tosed,  nonmetabolized  Ct-NBD-SM  reached  a  plateau 
value of ~ 27%  of the total cell-associated C6-NBD-lipid 
after 30 min at 37°C.  The amount of newly synthesized Ct- 
NBD-SM  produced during  the 2-h  incubation period in- 
creased steadily to ,x,15% of the total Ct-NBD-lipid, but re- 
mained less than the amount of internalized, nonmetabolized 
Ct-NBD-SM.  Also, only small amounts of newly synthe- 
sized fluorescent SM were transported to the plasma mem- 
brane during this period ('~3 % of the total Ct-NBD-lipid). 
Neither 10 #M monensin nor 10 #g/ml nocodazole inhibited 
either the Ct-NBD-SM internalization or Ct-NBD-GIcCer 
synthesis in Ct-NBD-SM-Iabeled cells (Table II). 
Plasma Membrane Recycling of Ct-NBD-SM 
Cells were labeled with Ct-NBD-SM under standard condi- 
tions, washed, incubated at 37°C for 30 min and then treated 
with back-exchange medium at 7°C to remove any fluores- 
cent SM remaining at the plasma membrane,  resulting in 
cells containing only internalized fluorescent lipid (Fig. 8 a). 
Cells containing only internalized fluorescent lipid were fur- 
ther incubated at 37°C in HMEM and the transport of Ct- 
NBD-lipid from intracellular compartments to the plasma 
membrane was observed (Fig. 8 b). When cells that had been 
further incubated at 37°C  were subsequently treated with 
back-exchange medium at 7°C,  to remove any fluorescent 
lipid that had returned to the plasma membrane, C6-NBD- 
lipid labeling in the periphery of the cell was revealed (Fig. 
8  c).  In contrast,  when cells containing only internalized 
C6-NBD-lipid were further incubated at 37°C  in back-ex- 
change medium, any C6-NBD-lipid transported to the plas- 
ma membrane from intracellular compartments was contin- 
Table II. Effect of Nocodazole and Monensin on Ct-NBD-SM Endocytosis 
C6-NBD-SM internalized  Ct-NBD-GIcCer  synthesized 
Percent of cell-  Percent of cell- 
associated  associated 
Treatment  pmol/#g DNA  Ct-NBD-lipid  pmol/#g DNA  C6-NBD-lipid 
Control  5.24  +  0.60  28.1  _+  3.2  0.33  +  0,05  1,7  +  0,3 
10 pM  monensin  6,20  +  2.10  33.3  +  11.3  0.53  +  0.11  2.8  +  0.6 
10 p.g/ml nocodazole  3.76  -t-  0.39  37.9  +  3.9  0.40  -I- 0.04  4.0  +  0.4 
Cells were either untreated  (control)  or were preincubated  with 10 ttM monensin or 10 #g/ml nocodazole  in culture medium for 90 min at 37°C. All solutions 
used for treated cells contained  either 10 #M monensin or 10 #g/ml nocodazole.  Cells were labeled with SUV containing o-erythro-Ct-NBD-SM in HMEM for 
30 rain at 7°C, washed, incubated  in HMEM at 37°C for 30 min, and either harvested immediately or treated with back-exchange medium at 7°C. The cell- 
associated lipids were extracted, and both the amount of endocytosed,  nonmetabolized  Ct-NBD-SM  and of newly synthesized Ct-NBD-GIcCer  were determined 
as described in the legend to Fig. 7.  Data are the mean of triplicate measurements +  SD. 
The Journal of Cell Biology, Volume 108, 1989  2176 Figure 8.  Recycling of intracellular  C6-NBD-SM to the plasma membrane.  (a) Cells were labeled with SUV containing o-erythro-C6- 
NBD-SM in HMEM for 30 min at 7°C, washed,  incubated at 37°C for 30 min in HMEM, and treated with back-exchange medium at 
7°C resulting in cells containing only internalized C6-NBD-lipid. (b) Cells treated as in a were further incubated at 37°C in HMEM for 
30 min, washed, and photographed.  The plasma membrane (arrowheads) showed the reappearance of fluorescent lipid labeling. (c) Ceils 
treated as in b were then treated  with back-exchange medium at 7°C to remove any C6-NBD-lipid returned  to the plasma membrane, 
washed, and photographed.  Note peripheral  endosomes containing reinternalized fluorescent lipid.  (d) Cells treated as in a were further 
incubated for 30 min at 37°C in back-exchange medium that continuously  removed any C6-NBD-lipid being transported  to the plasma 
membrane from intracellular compartments during the 37°C incubation.  The cells were then washed and photographed.  Note the lack of 
fluorescently labeled peripheral vesicles in d versus c. In some cases, perinuclear labeling was not visible for each cell in the field because 
of the plane of focus selected.  Bar,  10 #m. 
uously removed to acceptor vesicles (Fig. 8 d). Cells treated 
in  this  manner  showed very little  labeling  of intracellular 
vesicles in the periphery of the cell, suggesting that labeling 
of the cell periphery shown in Fig.  8  c was because of the 
further  internalization  of C6-NBD-lipid  that  had  been  re- 
turned to the plasma membrane. 
Quantitative analysis of cells containing only internalized 
D-erythro-C6-NBD-SM  that  were  further  incubated  for 30 
min  determined  that  3.03  +  0.22  (n  =  3)  pmole of non- 
metabolized  C6-NBD-SM/#g  DNA  was  recycled  back  to 
the plasma membrane, while the combined amount of newly 
synthesized  C6-NBD-SM  and  C6-NBD-GIcCer resulted  in 
only 0.46  +  0.31  (n  =  3) pmole/#g DNA.  Thus, >86%  of 
the plasma membrane fluorescence observed in Fig. 8 b was 
the result of the recycling of nonmetabolized C6-NBD-SM. 
The  time course of nonmetabolized  D-erythro-C6-NBD- 
SM return to the plasma membrane from intracellular com- 
partments was also determined (Fig.  9).  C6-NBD-SM was 
transported to the plasma membrane from intracellular com- 
partments with a half-time of ~15-20 min. Combined with 
a half-time of ~15-20 min for C6-NBD-SM internalization 
(Fig. 7), this gives a half-time for one complete round of re- 
cycling of "~, 30-40 min. 
The effects of 10 #g/ml monensin on C6-NBD-SM recy- 
cling  were also  examined  (Table III).  Similar amounts  of 
transport of nonmetabolized,  intracellular  C6-NBD-SM to 
the  plasma  membrane  occurred  in  monensin-treated  and 
control cells.  However, transport of newly synthesized C6- 
NBD-SM to the plasma membrane was abolished, consistent 
with previous results (25). 
In spite of the  altered  pattern of C6-NBD-SM  internal- 
ization (Fig. 4 c), nocodazole-treated cells exhibited plasma 
membrane recycling of nonmetabolized C6-NBD-SM (Table 
III). Neither the return of nonmetabolized C6-NBD-SM to 
the plasma membrane nor the transport of newly synthesized 
C6-NBD-SM were inhibited  by nocodazole.  In fact, noco- 
dazole appeared to increase the amount of newly synthesized 
C6-NBD-SM transport to the plasma membrane. 
Since C6-NBD-SM was capable of recycling, we wanted 
to  compare  the  distribution  of  internalized  C6-NBD-SM 
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Figure  9.  Quantitation of internalized  C6-HBD-SM  returned to 
the plasma membrane. Cells were labeled with SUV containing 
D-erythro-C6-NBD-SM in HMEM at 7°C for 30 min, washed, in- 
cubated  at  37°C for  30  min,  and  treated  with back-exchange 
medium  at  7°C  to  remove any  C6-NBD-SM remaining  at  the 
plasma membrane. The cells were then further incubated for the in- 
dicated amount of time at 37°C in either HMEM or back-exchange 
medium, washed, and the cell-associated lipids were extracted and 
analyzed by TLC (see Materials and Methods). The amount of non- 
metabolized C6-NBD-SM returned to the plasma membrane was 
calculated  using Eqs.  1-3. (B)  D-erythro-C6-NBD-SM and 
returned to the plasma membrane; ([]) intracellular D-erythro-C6- 
NBD-SM. Data points are the mean of triplicate measurements _+ 
SD and are expressed as the percentage of  total cell-associated, non- 
metabolized C6-NBD-SM. 
with that of Rh-Tf, a recycling protein (45). Cells were la- 
beled with C6-NBD-SM at 7°C under standard conditions, 
washed, and then incubated for 30 min at 37°C in HMEM 
containing Rh-Tf. As shown in Fig.  10,  both C6-NBD-SM 
and Rh-Tf were internalized to the central region of the cell; 
however, some intracellular vesicles in the periphery of the 
cell appeared to be labeled only by C6-NBD-SM. This could 
be, in part, because of a difference in the sensitivity of C6- 
NBD-lipid detection versus Rh-Tf detection. 
Discussion 
In this study, we have examined the transport of the o-erythro 
and L-threo stereoisomers of a fluorescent analogue of sphin- 
gomyelin,  C6-NBD-SM,  as  probes  for plasma  membrane 
lipid transport in CHO-KI  cells.  Most of the intracellular 
C6-NBD-SM  was  transported along the recycling pathway 
illustrated in Fig.  11, pathway I. Both isomers of C~-NBD- 
SM labeled only the plasma membrane when incubated with 
cells at  7°C.  Cells  labeled with  C6-NBD-SM  at 7°C  and 
then  incubated  at  37°C  endocytosed fluorescent SM  to a 
perinuclear region of the cell that colocalized with the centri- 
ole. When cells containing only internalized C6-NBD-lipid 
were further incubated at 37°C, C6-NBD-SM was returned 
to the plasma membrane.  Thus, C6-NBD-SM recycles be- 
tween  the  plasma  membrane  and  intracellular  compart- 
ments. Both D-erythro and L-threo-C6-NBD-SM were capa- 
ble of being recycled. 
In addition to the endocytosis of C6-NBD-SM, some hy- 
drolyis of both C6-NBD-SM isomers to the corresponding 
C6-NBD-Cer isomer was observed upon 37°C  incubation. 
C6-NBD-Cer can spontaneously undergo transbilayer move- 
ment (31),  in contrast to C6-NBD-SM  which has a highly 
polar head group restricting it to one leaflet of a bilayer (17). 
Thus,  as  illustrated  in  Fig.  11,  pathway  H,  C~-NBD-Cer 
produced by the hydrolysis of C6-NBD-SM was transported 
to the Golgi apparatus, presumably by spontaneous diffusion 
(30, 33), where it was converted back to fluorescent SM and, 
in the case of D-erythro-C6-NBD-SM, to fluorescent GlcCer. 
Consistent with the synthesis of C6-NBD-SM at the Golgi 
apparatus  (30) and the transport of newly synthesized C6- 
NBD-SM through the Golgi apparatus (25), the transport of 
newly  synthesized C6-NBD-SM  to the  plasma  membrane 
was inhibited by monensin, while the recycling of nonmetab- 
olized C6-NBD-SM was  not affected by monesin treatment 
(Table III). 
Fig.  11 depicts the partial hydrolysis of C6-NBD-SM oc- 
curring at the plasma membrane. This is consistent with our 
observation that some hydrolysis of D-erythro-C6-NBD-SM 
occurred at  7°C,  in  the  absence  of endocytosis.  Neutral 
sphingomyelinases have been found in plasma membrane- 
enriched fractions from rat liver (16),  neuroblastoma cell 
cultures (5), and human renal proximal tubule cell cultures 
(9). It is possible that C6-NBD-SM was also hydrolyzed by 
lysosomal (acid) sphingomyelinase (1, 7,  18);  however, C6- 
NBD-SM  did  not accumulate  in  the  lysosomes, probably 
because of the  sorting  of endocytosed C6-NBD-SM  from 
the degradation pathway to a  recycling pathway.  Also,  in- 
creasing  lysosomal pH with  NH4CI,  which  should reduce 
lysosomal  sphingomyelinase  activity,  did  not  inhibit  C6- 
NBD-SM hydrolysis (data not shown).  Examination of C6- 
NBD-SM transport in Niemann-Pick fibroblasts, which are 
Table IlL Effect of Nocodazole and Monensin on C6-NBD-SM Recycling 
Treatment 
Percent of total C6-NBD-SM 
Nonmetabolized  New  Percent nonmetabolized  Percent new 
C6-NBD-SM  C6-NBD-SM  C~-NBD-SM  C6-NBD-SM 
recycled  transported  recycled  transported 
Control  43.3  +  4.2  4.0  ±  2.8  68.7  +  9.8  10.8  +  1.0 
10/~M  monensin  56.1  _+  19.1  O*  76.0  _+  25.9  O* 
10/~g/ml nocodazole  46.8  +  5.9  9.9  _+  1.8  60.8  +  7.7  43.0  +  7.8 
Cells were either untreated (control) or preincubated with 10 #M monensin or  10 #g/mt nocodazole in culture medium for 90 min at 37°C.  All solutions used 
for treated cells contained either  10 p,M monensin or  10 #g/ml nocodazole. Cells were labeled with SUV containing D-erythro-C6-NBD-SM in HMEM  for 30 
rain at 7°C, washed, incubated at 370C in HMEM for 30 min, and then treated with back-exchange medium to remove any C6-NBD-SM remaining at the plasma 
membrane. The cells were then further incubated at 37°C for 30 min in either HMEM or back-exchange medium and washed. The cell-associated lipids were 
extracted and both the amount of nonmetabolized C6-NBD-SM recycled to the plasma membrane and of newly synthesized C6-NBD-SM transported to the plasma 
membrane were determined as described in the legend to Fig. 9.  Data are the mean of triplicate measurements +  SD,  expressed as percent total cell-associated 
C6-NBD-SM. 
* Not detectable. 
The Journal of Cell Biology, Volume  108,  1989  2178 Figure 10. Colocalization  of internalized C6-NBD-SM and Rh-Tf. Cells were labeled with SUV containing o-erythro-C6-NBD-SM at 7°C, 
washed, and incubated at 37°C for 30 min in HMEM that contained 20 #g/ml Rh-Tf. The cells were treated with back-exchange medium 
at 7°C to remove any C6-NBD-SM remaining at the plasma membrane and then photographed  for either C6-NBD-lipid (a) or Rh-Tf (b) 
fluorescence.  Bar,  10/xm. ~) ~  Golgi~ 
Figure 11.  Model of Cr-NBD-SM transport and recycling. Thick 
lines represent portions of the bilayer containing fluorescent lipid. 
Pathway 1,  nonmetabolized Cr-NBD-SM inserted into the outer 
leaflet of  the plasma membrane (PM) is endocytosed to intracellular 
vesicles in the region of the centriole. The internalized Cr-NBD- 
SM is subsequently transported from intracellular compartments 
back to the plasma membrane, resulting in a plasma membrane 
lipid recycling pathway. Pathway H, a small amount of Cr-NBD- 
SM is hydrolyzed to Cr-NBD-Cer at the plasma membrane. The 
fluorescent Cer produced spontaneously moves to the Golgi appara- 
tus  where  it  is  metabolized to newly synthesized Cr-NBD-SM 
and,  in the case of D-erythro-Cr-NBD-Cer, to C6-NBD-GIcCer. 
The metabolites are then transported from the Golgi apparatus to 
the plasma membrane by a process that is inhibited by monensin 
treatment. 
deficient in  lysosomal sphingomyelinase,  may help deter- 
mine the relative importance of these two sites of SM hydro- 
lysis in the cell. 
Cr-NBD-SM-Iabeled CHO-K1 cells internalized fluores- 
cent SM that accumulated in intracellular vesicles associated 
with the centriole. These"perinuclear" endosomes have been 
observed in a variety of systems (for review, see 15) and are 
distinct  from  peripheral  endosomal  compartments.  The 
Golgi apparatus is often associated with the centriole, partic- 
ularly when migrating fibroblasts are examined (36). Previ- 
ous work from our laboratory indicates that a  fluorescent 
analogue  of phosphatidylcholine is  internalized  from the 
plasma membrane and transported to the region of the Golgi 
apparatus in Chinese hamster V79 fibroblasts (37). In CHO- 
K1 cells, we found that the Golgi apparatus and perinuclear 
endosomes were not usually juxtaposed, suggesting that the 
extent of colocalization of these compartments depends on 
the cell type. 
The association of intracellular compartments with micro- 
tubules has been examined elsewhere (8, 13, 28, 42). Disrup- 
tion of the microtubules did not inhibit the endocytosis or re- 
cycling of Cr-NBD-SM; however, intracellular vesicles con- 
raining fluorescent SM no longer accumulated in the central 
region of the cell. Consistent with these results, transferrin 
also recycles in microtubule-disrupted cells (12). Consistent 
with  these  studies,  recycling of Cr-NBD-SM  was  not in- 
hibited by disruption of microtubules with nocodazole. 
One round of C6-NBD-SM recycling occurs with a half- 
time of ,,o40 min in CHO-K1 cells. In contrast, the half-time 
for transferrin recycling in CHO cells is '~15 min (47). The 
slower  rate  of  Cr-NBD-SM  recycling  is  not  surprising, 
since rapidly recycling receptors are actively clustered into 
coated pits  (10),  while lipids  are  likely to undergo rapid 
random lateral diffusion throughout the plasma membrane 
bilayer. 
Max  field and co-workers have shown that fluorescently la- 
beled transferrin segregates into a perinuclear compartment 
upon endocytosis in CHO-WTT2 cells that they identify as 
a postsegregation compartment along the exocytic portion of 
the plasma membrane recycling pathway (47). We have found 
that Rh-Tf and Cr-NBD-SM are endocytosed to the same 
compartment  by  CHO-K1  cells  during  37°C  incubation. 
Whether all plasma membrane proteins and lipids recycle 
through this compartment is unknown at present. The use of 
Cr-NBD-SM in conjunction with fluorescently labeled pro- 
teins will enable the simultaneous visualization and mea- 
surement of  lipid and protein transport in future studies. This 
approach could determine the extent to which plasma mem- 
brane  recycling  pathways  taken  by  proteins  and  lipids 
coincide. 
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